ImpriMed offers a unique precision oncology service that helps you to find the best anticancer drugs for your patients.ImpriMed directly tests a panel of commonly used anticancer drugs on your patients’ live cells in our A2LA accredited lab.In addition, we continually collect patient outcomes that are updated via regular follow-up with pet parents.As our database grows, so does the performance of our anticancer drug response predictions and your ability to develop a personalized treatment plan for each pet patient.So, when you order an ImpriMed service, you are actively contributing to our dataset and helping to improve cancer care for your patients and the ImpiMed user community.